🍽🦠 PubMed Studies Citing Bacteria Shifts for [ofloxacin (antibiotic)s]

Citations are updated once a week. Recently added citations may not appear.

10 Citations Found, Full List Requires Login Summary Publisher Link Html Article Download Article Why do I only have some/no links buttons showing?
πŸ““ - Direct Citation   |   πŸ‘ͺ - Infer Parent  |   πŸ‘Ά - Infer Child |   βš—οΈ - Inferred from bacteria association
For Samples: 😁 - Shifts in right direction   |   😒 - Shifts in wrong direction
Context Citation
ofloxacin (antibiotic)s    ? Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon.
African health sciences (Afr Health Sci ) Vol: 6 Issue 4 Pages: 232-5
Pub: 2006 Dec Epub: Authors Gangoue-Pieboji J , Koulla-Shiro S , Ngassam P , Adiogo D , Ndumbe P ,
Html Article Publication
ofloxacin (antibiotic)s    ? Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother ) Vol: 40 Issue 4 Pages: 1048-9
Pub: 1996 Apr Epub: Authors Kenny GE , Cartwright FD ,
Html Article Publication
ofloxacin (antibiotic)s    ? Unravelling the collateral damage of antibiotics on gut bacteria.
Nature (Nature ) Vol: 599 Issue 7883 Pages: 120-124
Pub: 2021 Nov Epub: 2021 Oct 13 Authors Maier L , Goemans CV , Wirbel J , Kuhn M , Eberl C , Pruteanu M , Müller P , Garcia-Santamarina S , Cacace E , Zhang B , Gekeler C , Banerjee T , Anderson EE , Milanese A , Löber U , Forslund SK , Patil KR , Zimmermann M , Stecher B , Zeller G , Bork P , Typas A ,
Publication
ofloxacin (antibiotic)s    ? Estimating modifiers from bacteria associations
Microbiome Prescription (Lassesen Consulting, LLC ) Vol: 2023 Issue 3 Pages: 3342-3347
Pub: 2023 Apr Epub: Authors K Lassesen ,
Publication
ofloxacin (antibiotic)s    ? The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea.
The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 66 Issue 9 Pages: 2038-44
Pub: 2011 Sep Epub: 2011 Jun 16 Authors Dridi B , Fardeau ML , Ollivier B , Raoult D , Drancourt M ,
Publication

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.